Irimia obtained a Bachelor’s degree in Biotechnology in 2024 from the University of Santiago de Compostela, where she also completed her Bachelor’s Thesis in our Cellular Senescence, Cancer and Aging laboratory. She then completed a Master’s degree in Genetics and Genomics at the same university, carrying out her Master’s Thesis in our laboratory as well. In October 2025, she joined the laboratory as a PhD student, supported by an FPU fellowship. Her research focuses on the role of the cell cycle regulators p21 and p16 in therapy-induced senescence, aiming to improve cancer treatment strategies.
